Risk factors
Spruce Biosciences (SPRB) risk factors
Item 1A of every Spruce Biosciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors87 risks15 new14 dropped28 reworded
Spruce Biosciences faces substantial financial losses and relies heavily on ongoing clinical development of TA-ERT and tildacerfont.
Filed Mar 09, 2026 - FY2024 10-K risk factors86 risks
Spruce Biosciences faces substantial going concern doubt with only $38.8 million in cash as of December 31, 2024.
Filed Apr 15, 2025